Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2005 2
2006 4
2007 6
2008 7
2009 1
2010 4
2011 6
2012 7
2013 16
2014 11
2015 12
2016 8
2017 7
2018 17
2019 16
2020 25
2021 36
2022 40
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Chisari CG, Aguglia U, Amato MP, Bergamaschi R, Bertolotto A, Bonavita S, Morra VB, Cavalla P, Cocco E, Conte A, Cottone S, De Luca G, Di Sapio A, Filippi M, Gallo A, Gasperini C, Granella F, Lus G, Maimone D, Maniscalco GT, Marfia G, Moiola L, Paolicelli D, Pesci I, Ragonese P, Rovaris M, Salemi G, Solaro C, Totaro R, Trojano M, Vianello M, Zaffaroni M, Lepore V, Patti F; Italian MS Register Study Group. Chisari CG, et al. Neurotherapeutics. 2024 May 7:e00363. doi: 10.1016/j.neurot.2024.e00363. Online ahead of print. Neurotherapeutics. 2024. PMID: 38714462
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
Galosi E, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Lauletta A, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Esposito N, Falco P, di Pietro G, Truini A, Leonardi L. Galosi E, et al. Among authors: salvetti m. Neurol Sci. 2024 May 3. doi: 10.1007/s10072-024-07562-0. Online ahead of print. Neurol Sci. 2024. PMID: 38700599
EBV infection drives MS pathology: Yes.
Aloisi F, Salvetti M. Aloisi F, et al. Among authors: salvetti m. Mult Scler. 2024 Apr;30(4-5):483-485. doi: 10.1177/13524585241235825. Mult Scler. 2024. PMID: 38602260 No abstract available.
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
Arisi I, Malimpensa L, Manzini V, Brandi R, Gosetti di Sturmeck T, D'Amelio C, Crisafulli S, Ferrazzano G, Belvisi D, Malerba F, Florio R, Pascale E, Soreq H, Salvetti M, Cattaneo A, D'Onofrio M, Conte A. Arisi I, et al. Among authors: salvetti m. Front Immunol. 2023 Dec 13;14:1234869. doi: 10.3389/fimmu.2023.1234869. eCollection 2023. Front Immunol. 2023. PMID: 38152407 Free PMC article.
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.
Koudriavtseva T, Lorenzano S, Cellerino M, Truglio M, Fiorelli M, Lapucci C, D'Agosto G, Conti L, Stefanile A, Zannino S, Filippi MM, Cortese A, Piantadosi C, Maschio M, Maialetti A, Galiè E, Salvetti M, Inglese M. Koudriavtseva T, et al. Among authors: salvetti m. Front Immunol. 2023 Jul 31;14:1226616. doi: 10.3389/fimmu.2023.1226616. eCollection 2023. Front Immunol. 2023. PMID: 37583699 Free PMC article.
210 results